Work

Changes in Glucose Breath Test in Cystic Fibrosis Patients Treated With 1 Month of Lumacaftor/Ivacaftor

Year: 2022

Type: article

Source: Journal of Pediatric Gastroenterology and Nutrition

DOI: 10.1097/mpg.0000000000003459

Authors: Megan E. Gabel, Hongyue Wang, Daniel Gelfond, Christine Roach, Steven M. Rowe, John P. Clancy, Scott D. Sagel, Drucy Borowitz

Institutions: University of Rochester Medicine, University of Rochester, University of Alabama at Birmingham, UAB Medicine, Cincinnati Children's Hospital Medical Center, Cystic Fibrosis Foundation, Children's Hospital Colorado, University of Colorado Anschutz

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: American Society for Pharmacology and Experimental Therapeutics

Awards: G3396168610, G7045244299, G7623444141

OpenAlex ID: W4224260182

FWCI: 1.128

Cites: 27

Cited by: 9

Related to: 10